Skip to main content
. 2021 Jan 12;16(1):e0244838. doi: 10.1371/journal.pone.0244838

Table 1. Sample characteristics.

OM n = 36 MBCT n = 32 FA n = 36 Total n = 104
Female, n (%) 26 (72.2) 23 (71.9) 27 (75.0) 76 (73.1)
Age, M (SD) 40.0 (13.2) 38.6 (12.4) 42.1 (12.8) 40.3 (12.8)
AD meds, n (%) 12 (33.3) 12 (37.5) 11 (30.6) 35 (33.7)
Race, n (%)
 White 35 (97.2) 31 (96.8) 36 (100) 102 (98.0)
 Asian 0 (0) 1 (3.2) 0 (0) 1 (1.0)
 Not reported 1 (2.8) 0 (0) 0 (0) 1 (1.0)
Ethnicity, n (%)
 Hispanic/Latino 4 (11.1) 2 (6.5) 1 (2.8) 7 (6.8)
 Non-Hispanic/Latino 32 (88.9) 30 (93.5) 35 (97.2) 97 (93.2)
Highest level of education, n (%)
 High school 1 (2.8) 2 (6.3) 0 (0) 3 (2.9)
 College 16 (44.4) 18 (56.3) 22 (61.1) 56 (53.8)
 Graduate 19 (52.8) 12 (37.5) 14 (38.9) 45 (43.3)
Axis I Diagnoses, n (%)
 Current clinical MDD 15 (41.7) 12 (37.5) 14 (38.9) 41 (39.4)
 Current clinical GAD 18 (50.0) 14 (43.8) 20 (55.6) 52 (50.0)
Participant Adherence
 Total randomized, n 36 32 36 104
 Completed intervention, n (%)a 31 (91.2) 30 (93.8) 35 (97.2) 96 (94.1)
 Classes attended, M (SD)b 7.7 (1.8) 7.7 (1.8) 8.1 (1.3) 7.8 (1.6)
Meditation Homework Compliance
 8wk formal min/wk, M (SD)b 215.9 (72.2) 185.2 (82.6) 205.6 (65.9) 202.6 (73.7)
 3mo formal min/wk, M (SD)b 104.2 (106.9) 97.8 (97.2) 100.0 (96.6) 100.7 (99.2)
Instructors
 Gender ratio (male: female)
 Combined meditation experience (years)
 # Clinical degrees
 # Ph.D.’s
 # MBSR/MBCT instructors

 1:1
 40
 1
 2
 1

 1:1
 40
 1
 2
 2

 1:1
 40
 2
 1
 2
Treatment Fidelity (%) 88.9 93.9 97.1 93.3

Note. AD meds = Antidepressant medication; MDD = Major Depressive Disorder; GAD = Generalized Anxiety Disorder; 8wk = during 8-week intervention; 3mo = period between week 8 and 3-month follow-up (week 20); # = “number of”.

aCompleters only include participants who began treatment (i.e., attended the first class). Two additional participants dropped from OM before the beginning of treatment.

bThese variables only include participants who completed all 8 weeks of treatment (FA, MBCT, OM n’s = 35, 30, 31, respectively).